Similar articles

• A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.

  Vonka V, Janda Z, Simon J, Adam E, Stárek M. Vonka V, et al. Prog Med Virol. 1967;9:204-55. Prog Med Virol. 1967. PMID: 4293687 Review. No abstract available.
• Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.

  [No authors listed] [No authors listed] Bull World Health Organ. 1969;40(6):925-45. Bull World Health Organ. 1969. PMID: 4310724 Free PMC article. No abstract available.
• [Studies on strains of poliomyelitis virus isolated in Poland during the 1959-1965 period. II. Interdependence between genetic markers of strains and their antigenic structure and neuropathological properties].

  Dobrowolska H, Stańczyk R. Dobrowolska H, et al. Med Dosw Mikrobiol. 1966;18(4):385-95. Med Dosw Mikrobiol. 1966. PMID: 4289230 Polish. No abstract available.
• Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.

  Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S. Horie H, et al. J Med Virol. 2002 Nov;68(3):445-51. doi: 10.1002/jmv.10224. J Med Virol. 2002. PMID: 12226835
• Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.

  Racaniello VR, Ren R, Bouchard M. Racaniello VR, et al. Dev Biol Stand. 1993;78:109-16. Dev Biol Stand. 1993. PMID: 8388820 Review.